Summary
Novartis AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novartis AG (Novartis) is engaged in research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It provides a diverse range of products across various therapeutic areas, including cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. Novartis distributes its products to a wide array of stakeholders, including pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems, under brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, on a global scale. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy. Novartis is headquartered in Basel, Switzerland.
Scope
- Detailed information on Novartis AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis
- An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments
- Intelligence on Novartis AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novartis AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Novartis AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novartis AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novartis AG's business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
Novartis AG: Company Overview
Novartis AG: Overview and Key Facts
Novartis AG: Overview
Novartis AG: Key Facts
Novartis AG: Key Employees
Novartis AG: Key Employee Biographies
Novartis AG: Major Products and Services
Novartis AG: Management Statement
Novartis AG: Locations and Subsidiaries
Novartis AG: Key Competitors
Novartis AG: Company Analysis
Novartis AG: Business Description
Novartis AG: SWOT Analysis
Novartis AG: SWOT Overview
Novartis AG: Strengths
Novartis AG: Weaknesses
Novartis AG: Opportunities
Novartis AG: Threats
Novartis AG: Corporate Financial Deals Activity
Novartis AG: Financial Deals Overview
Novartis AG: Targets and Partners
Novartis AG: Top Deals 2021 - 2025YTD*
Novartis AG: Advisors
Novartis AG: Top Legal Advisors
Novartis AG: Top Financial Advisors
Novartis AG: Mergers and Acquisitions
Novartis AG: Corporate Venturing
Novartis AG: Partnership
Novartis AG: Divestments
Novartis AG: Recent Developments
Novartis AG: News and Events Summary
Novartis AG: Business Expansion
Novartis AG: Corporate Governance
Novartis AG: Financial Performance
Novartis AG: Market Developments
Novartis AG: Research & Development
Novartis AG: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Novartis AG: Key Facts
Table 2: Novartis AG: Key Employees
Table 3: Novartis AG: Locations and Subsidiaries
Table 4: Novartis AG: Key Competitors
Table 5: Novartis AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Novartis AG: M&A Activity by Geography (TTM*)
Table 7: Novartis AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 8: Novartis AG: M&A Average Deal Size - Value (US$m)
Table 9: Novartis AG: Targets and Partners
Table 10: Novartis AG: Top Deals 2021 - 2025YTD*
Table 11: Novartis AG: Legal Advisor Ranking by Value (US$m)
Table 12: Novartis AG: Financial Advisor Ranking by Value (US$m)
Table 13: Novartis AG: M&A Volume and Value Trend (2021 - YTD*2025)
Table 14: Novartis AG: M&A Activity by Geography (2021 - YTD*2025)
Table 15: Novartis AG: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Table 16: Novartis AG: Corporate Venturing by Geography (2021 - YTD*2025)
Table 17: Novartis AG: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 18: Novartis AG: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 19: Novartis AG: Divestments Volume and Value Trend (2021 - YTD*2025)
Table 20: Novartis AG: Divestments by Geography (2021 - YTD*2025)
Table 21: Novartis AG: News and Events Summary
Table 22: Novartis AG: Business Expansion
Table 23: Novartis AG: Corporate Governance
Table 24: Novartis AG: Financial Performance
Table 25: Novartis AG: Market Developments
Table 26: Novartis AG: Research & Development
Table 27: Novartis AG: Strategy and Operations
List of Figures
Figure 1: Novartis AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Novartis AG: M&A Activity by Geography (TTM*)
Figure 3: Novartis AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 4: Novartis AG: M&A Average Deal Size - Value (US$m)
Figure 5: Novartis AG: M&A Volume and Value Trend (2021 - YTD*2025)
Figure 6: Novartis AG: M&A Activity by Geography (2021 - YTD*2025)
Figure 7: Novartis AG: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Figure 8: Novartis AG: Corporate Venturing by Geography (2021 - YTD*2025)
Figure 9: Novartis AG: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 10: Novartis AG: Partnership Trend by Deal Type (2021 - YTD*2025)
Figure 11: Novartis AG: Divestments Volume and Value Trend (2021 - YTD*2025)
Figure 12: Novartis AG: Divestments by Geography (2021 - YTD*2025)
